» Articles » PMID: 36753517

Informing the Development of Diagnostic Criteria for Differential Diagnosis of Alcohol-related Cognitive Impairment (ARCI) Among Heavy Drinkers: A Systematic Scoping Review

Overview
Journal PLoS One
Date 2023 Feb 8
PMID 36753517
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early detection and diagnosis of alcohol-related cognitive impairment (ARCI) among heavy drinkers is crucial to facilitating appropriate referral and treatment. However, there is lack of consensus in defining diagnostic criteria for ARCI. Uncertainty in attributing a diagnosis of suspected ARCI commonly arises in clinical practice and opportunities to intervene are missed. A systematic scoping review approach was taken to (i) summarise evidence relating to screening or diagnostic criteria used in clinical studies to detect ARCI; and (ii) to determine the extent of the research available about cognitive assessment tools used in 'point-of-care' screening or assessment of patients with suspected non-Korsakoff Syndrome forms of ARCI.

Methods: We searched Medline, PsycINFO, Cinahl and the Web of Science, screened reference lists and carried out forward and backwards citation searching to identify clinical studies about screening, diagnosis or assessment of patients with suspected ARCI.

Results: In total, only 7 studies met our primary objective and reported on modifications to existing definitions or diagnostic criteria for ARCI. These studies revealed a lack of coordinated research and progress towards the development and standardisation of diagnostic criteria for ARCI. Cognitive screening tools are commonly used in practice to support a diagnosis of ARCI, and as a secondary objective we included an additional 12 studies, which covered a range of settings and patient populations relevant to screening, diagnosis or assessment in acute, secondary or community 'point-of-care' settings. Across two studies with a defined ARCI patient sample and a further four studies with an alcohol use disorder patient sample, the accuracy, validity and/or reliability of seven different cognitive assessment tools were examined. The remaining seven studies reported descriptive findings, demonstrating the lack of evidence available to draw conclusions about which tools are most appropriate for screening patients with suspected ARCI.

Conclusion: This review confirms the scarcity of evidence available on the screening, diagnosis or assessment of patients with suspected ARCI. The lack of evidence is an important barrier to the development of clear guidelines for diagnosing ARCI, which would ultimately improve the real-world management and treatment of patients with ARCI.

References
1.
Brown P, Heirene R, Gareth-Roderique-Davies , John B, Evans J . Applicability of the ACE-III and RBANS Cognitive Tests for the Detection of Alcohol-Related Brain Damage. Front Psychol. 2019; 10:2636. PMC: 6892773. DOI: 10.3389/fpsyg.2019.02636. View

2.
Ko K, Ridley N, Bryce S, Allott K, Smith A, Kamminga J . Screening Tools for Cognitive Impairment in Adults with Substance Use Disorders: A Systematic Review. J Int Neuropsychol Soc. 2021; 28(7):756-779. DOI: 10.1017/S135561772100103X. View

3.
Wilson K, Halsey A, Macpherson H, Billington J, Hill S, Johnson G . The psycho-social rehabilitation of patients with alcohol-related brain damage in the community. Alcohol Alcohol. 2012; 47(3):304-11. DOI: 10.1093/alcalc/agr167. View

4.
Nyblade L, Stockton M, Giger K, Bond V, Ekstrand M, Mc Lean R . Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019; 17(1):25. PMC: 6376713. DOI: 10.1186/s12916-019-1256-2. View

5.
van Boekel L, Brouwers E, van Weeghel J, Garretsen H . Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013; 131(1-2):23-35. DOI: 10.1016/j.drugalcdep.2013.02.018. View